Myron Czuczman - Oct 4, 2022 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Medical Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4
Date filed
10/6/2022, 04:05 PM
Previous filing
Oct 13, 2021
Next filing
Oct 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300K $0.00 300K Oct 4, 2022 Common Stock 300K $1.25 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 4, 2022 Common Stock 300K $2.04 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 500K Oct 4, 2022 Common Stock 500K $1.19 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3 One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date.